223 related articles for article (PubMed ID: 20608898)
1. A novel virally inactivated human platelet lysate preparation rich in TGF-beta, EGF and IGF, and depleted of PDGF and VEGF.
Burnouf PA; Juan PK; Su CY; Kuo YP; Chou ML; Su CH; Tseng YH; Lin CT; Burnouf T
Biotechnol Appl Biochem; 2010 Aug; 56(4):151-60. PubMed ID: 20608898
[TBL] [Abstract][Full Text] [Related]
2. A virally inactivated functional growth factor preparation from human platelet concentrates.
Su CY; Kuo YP; Lin YC; Huang CT; Tseng YH; Burnouf T
Vox Sang; 2009 Aug; 97(2):119-28. PubMed ID: 19320900
[TBL] [Abstract][Full Text] [Related]
3. A virally inactivated platelet-derived growth factor/vascular endothelial growth factor concentrate fractionated from human platelets.
Burnouf T; Kuo YP; Huang CT; Tseng YH; Lin CT; Su CY
Transfusion; 2010 Aug; 50(8):1702-11. PubMed ID: 20412527
[TBL] [Abstract][Full Text] [Related]
4. Solvent/detergent treatment of platelet concentrates enhances the release of growth factors.
Burnouf T; Tseng YH; Kuo YP; Su CY
Transfusion; 2008 Jun; 48(6):1090-8. PubMed ID: 18373502
[TBL] [Abstract][Full Text] [Related]
5. A chromatographically purified human TGF-β1 fraction from virally inactivated platelet lysates.
Burnouf T; Chang CW; Kuo YP; Wu YW; Tseng YH; Su CY
Vox Sang; 2011 Oct; 101(3):215-20. PubMed ID: 21521235
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture.
Toda S; Nishimura T; Yamada S; Koike N; Yonemitsu N; Watanabe K; Matsumura S; Gärtner R; Sugihara H
J Pathol; 1999 Aug; 188(4):415-22. PubMed ID: 10440753
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the kinetics of growth factors release from platelet gel.
Su CY; Kuo YP; Nieh HL; Tseng YH; Burnouf T
Transfusion; 2008 Nov; 48(11):2414-20. PubMed ID: 18694465
[TBL] [Abstract][Full Text] [Related]
8. In vitro release of growth factors from platelet-rich fibrin (PRF): a proposal to optimize the clinical applications of PRF.
Su CY; Kuo YP; Tseng YH; Su CH; Burnouf T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Jul; 108(1):56-61. PubMed ID: 19451002
[TBL] [Abstract][Full Text] [Related]
9. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells.
Ogino Y; Ayukawa Y; Kukita T; Koyano K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jun; 101(6):724-9. PubMed ID: 16731390
[TBL] [Abstract][Full Text] [Related]
10. A novel drilling procedure and subsequent bone autograft preparation: a technical note.
Anitua E; Carda C; Andia I
Int J Oral Maxillofac Implants; 2007; 22(1):138-45. PubMed ID: 17340908
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of autologous platelet-rich gel for diabetic refractory dermal ulcer and growth factors analysis from it].
Yuan N; Wang C; Wang Y; Yu T; Long Y; Zhang X; Ran X
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):468-71. PubMed ID: 18575451
[TBL] [Abstract][Full Text] [Related]
12. Differential inhibitory effects of TGF-beta on EGF-, PDGF-, and HBGF-1-stimulated MG63 human osteosarcoma cell growth: possible involvement of growth factor interactions at the receptor and postreceptor levels.
Mioh H; Chen JK
J Cell Physiol; 1989 Jun; 139(3):509-16. PubMed ID: 2472412
[TBL] [Abstract][Full Text] [Related]
13. Growth regulation in primary culture of rabbit arterial smooth muscle cells by platelet-derived growth factor, insulin-like growth factor-I, and epidermal growth factor.
Yamamoto M; Yamamoto K
Exp Cell Res; 1994 May; 212(1):62-8. PubMed ID: 8174643
[TBL] [Abstract][Full Text] [Related]
14. Preliminary separation of the growth factors in platelet-rich plasma: effects on the proliferation of human marrow-derived mesenchymal stem cells.
Huang Q; Wang YD; Wu T; Jiang S; Hu YL; Pei GX
Chin Med J (Engl); 2009 Jan; 122(1):83-7. PubMed ID: 19187622
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the platelet concentrate collection system with the plasma-rich-in-growth-factors kit to produce platelet-rich plasma: a technical report.
Weibrich G; Kleis WK; Hitzler WE; Hafner G
Int J Oral Maxillofac Implants; 2005; 20(1):118-23. PubMed ID: 15747683
[TBL] [Abstract][Full Text] [Related]
16. Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate.
Shih DT; Chen JC; Chen WY; Kuo YP; Su CY; Burnouf T
Transfusion; 2011 Apr; 51(4):770-8. PubMed ID: 21044088
[TBL] [Abstract][Full Text] [Related]
17. Tumor secretion of growth factors.
Daughaday WH; Deuel TF
Endocrinol Metab Clin North Am; 1991 Sep; 20(3):539-63. PubMed ID: 1718747
[TBL] [Abstract][Full Text] [Related]
18. A novel selective progesterone receptor modulator asoprisnil (J867) down-regulates the expression of EGF, IGF-I, TGFbeta3 and their receptors in cultured uterine leiomyoma cells.
Wang J; Ohara N; Wang Z; Chen W; Morikawa A; Sasaki H; DeManno DA; Chwalisz K; Maruo T
Hum Reprod; 2006 Jul; 21(7):1869-77. PubMed ID: 16613890
[TBL] [Abstract][Full Text] [Related]
19. Platelet-rich plasma preparation using three devices: implications for platelet activation and platelet growth factor release.
Everts PA; Brown Mahoney C; Hoffmann JJ; Schönberger JP; Box HA; van Zundert A; Knape JT
Growth Factors; 2006 Sep; 24(3):165-71. PubMed ID: 17079200
[TBL] [Abstract][Full Text] [Related]
20. Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells.
Wahlström O; Linder C; Kalén A; Magnusson P
Platelets; 2007 Mar; 18(2):113-8. PubMed ID: 17365859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
